Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.
about
Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene familyMechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylationStructural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeatsOxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseasesThe glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.Testis-specific glyceraldehyde-3-phosphate dehydrogenase: origin and evolutionMeclizine is neuroprotective in models of Huntington's disease.Perturbed glucose metabolism: insights into multiple sclerosis pathogenesiswasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early deathOxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cellsRoles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease.Nuclear translocation and accumulation of glyceraldehyde-3-phosphate dehydrogenase involved in diclazuril-induced apoptosis in Eimeria tenella (E. tenella).Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment.Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodiumMolecular mechanisms and clinical implications of reversible protein S-glutathionylation.Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease.An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicityRapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase.Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis PatientsDifferential expression of proteins in brain regions of Alzheimer's disease patients.Modifications of glyceraldehyde-3-phosphate dehydrogenase induced by increasing concentrations of peroxynitrite: early recognition by 20S proteasome.BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways.Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.A proteomic approach for the involvement of the GAPDH in Alzheimer disease in the blood of Moroccan FAD cases.Streptococcus pneumoniae secretes a glyceraldehyde-3-phosphate dehydrogenase, which binds haemoglobin and haem.Disturbed Glucose Metabolism in Rat Neurons Exposed to Cerebrospinal Fluid Obtained from Multiple Sclerosis Subjects.Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients.Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology
P2860
Q24562672-8CB313EE-B9B7-45DE-89E9-CDA07E25BDB2Q26830954-641B356F-1CAB-42A8-AC09-AEE1A983A6B6Q31122113-1CC5294D-020D-4929-BCF1-458B80045B88Q33639885-271C29E2-0A8D-46CE-9C89-820DE2A1C564Q33851008-A5494834-217B-4FCE-B870-A8DAA46C5F93Q33898316-B6337AEB-869A-444C-94EB-DE1CE94881F8Q33929601-83D4F591-E765-47A6-A141-DFFAB84BE3DAQ34424265-3B71DAAA-8FA9-4E05-AA6E-E598E63E0331Q34595607-E0121841-26A0-4D4F-8E53-93335CB1E22EQ35056697-87E02E24-3D0D-416F-BF3B-1FD54B6E88D3Q35677091-BFC10B1D-D982-4BCE-AE1E-C4752434646FQ35993403-1B9D6D91-F383-42A7-ADDF-4B17335086CEQ36076365-53B6EFB5-A538-4409-8FAE-6E363F580874Q36159463-34C19B56-C144-4DBB-BE11-8439F4C500C7Q36847277-CB8C8326-AD48-418E-ABAA-456491E659C3Q37027391-C49E6BBE-2599-460E-8FAB-1351F01C025CQ37052151-4494DDA8-EFA7-4458-A582-57A80FBE130AQ37262124-8AEEB540-CB57-4AF3-BE3E-08014E5CC07BQ37453183-B3A5F2E7-A50B-458E-8880-0B6EEC83CBA0Q38038981-1D769DBC-548E-4693-9FF1-80D2F0EA72E5Q40614792-755F0EF1-6507-4BBE-A003-93AF03146264Q41063803-79F552A1-FAFF-414F-A74E-D6CBF8C32A3DQ43809348-C53723FE-F7DC-4A68-9E0F-1F8F5E9B5EDBQ44390234-3951269E-6AED-4988-8332-8FD84AD3E945Q45068656-A641F9E6-B599-489C-A3FB-C453720567F4Q45290567-C5625601-28A6-48D8-9489-3F58A9504EBBQ46202439-33033E41-31BD-4C05-88BC-A7C5501B43A6Q46256458-6E02C452-0552-47CD-B9E6-78F244415F71Q47265472-DACBBB03-F39F-4601-BD3A-70A68D53DC94Q48604330-9F13ED2E-7961-44B8-A35D-38E67BD99041Q58727014-0D4E022A-FE83-4CC1-891F-61C1619F86C8
P2860
Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@ast
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@en
type
label
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@ast
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@en
prefLabel
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@ast
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@en
P2860
P1476
Reduction of glyceraldehyde-3- ...... tington's disease fibroblasts.
@en
P2093
Mazzola JL
Sirover MA
P2860
P304
P356
10.1046/J.1471-4159.2001.00033.X
P407
P577
2001-01-01T00:00:00Z